Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Risk factors for acquisition of carbapenem-resistance during treatment with carbapenem in the intensive care unit: a prospective study.

Labaste F, Grossac J, Bounes FV, Conil JM, Ruiz S, Seguin T, Grare M, Fourcade O, Minville V, Georges B.

Eur J Clin Microbiol Infect Dis. 2019 Sep 3. doi: 10.1007/s10096-019-03644-6. [Epub ahead of print]

PMID:
31482416
2.

Risk factors and the resistance mechanisms involved in Pseudomonas aeruginosa mutation in critically ill patients.

Druge S, Ruiz S, Vardon-Bounes F, Grare M, Labaste F, Seguin T, Fourcade O, Minville V, Conil JM, Georges B.

J Intensive Care. 2019 Jul 19;7:36. doi: 10.1186/s40560-019-0390-4. eCollection 2019.

3.

Elucidating Non-aqueous Solvent Stability and Associated Decomposition Mechanisms for Mg Energy Storage Applications From First-Principles.

Seguin TJ, Hahn NT, Zavadil KR, Persson KA.

Front Chem. 2019 Apr 9;7:175. doi: 10.3389/fchem.2019.00175. eCollection 2019.

4.

Hemodynamic efficiency of hemodialysis treatment with high cut-off membrane during the early period of post-resuscitation shock: The HYPERDIA trial.

Geri G, Grimaldi D, Seguin T, Lamhaut L, Marin N, Chiche JD, Pène F, Bouglé A, Daviaud F, Morichau-Beauchant T, Arnaout M, Champigneulle B, Zafrani L, Bourcier S, Nguyen YL, Charpentier J, Mira JP, Coste J, Vinsonneau C, Cariou A.

Resuscitation. 2019 Jul;140:170-177. doi: 10.1016/j.resuscitation.2019.03.045. Epub 2019 Apr 8.

PMID:
30974188
5.

Topological disintegration of resting state functional connectomes in coma.

Malagurski B, Péran P, Sarton B, Vinour H, Naboulsi E, Riu B, Bounes F, Seguin T, Lotterie JA, Fourcade O, Minville V, Ferré F, Achard S, Silva S.

Neuroimage. 2019 Jul 15;195:354-361. doi: 10.1016/j.neuroimage.2019.03.012. Epub 2019 Mar 9.

PMID:
30862533
6.

Neurally adjusted ventilatory assist (NAVA) versus pressure support ventilation: patient-ventilator interaction during invasive ventilation delivered by tracheostomy.

Lamouret O, Crognier L, Vardon Bounes F, Conil JM, Dilasser C, Raimondi T, Ruiz S, Rouget A, Delmas C, Seguin T, Minville V, Georges B.

Crit Care. 2019 Jan 7;23(1):2. doi: 10.1186/s13054-018-2288-2.

7.

Enhanced Stability of the Carba- closo-dodecaborate Anion for High-Voltage Battery Electrolytes through Rational Design.

Hahn NT, Seguin TJ, Lau KC, Liao C, Ingram BJ, Persson KA, Zavadil KR.

J Am Chem Soc. 2018 Sep 5;140(35):11076-11084. doi: 10.1021/jacs.8b05967. Epub 2018 Aug 21.

PMID:
30059211
8.

Anticoagulation Monitoring Under ECMO Support: A Comparative Study Between the Activated Coagulation Time and the Anti-Xa Activity Assay.

Delmas C, Jacquemin A, Vardon-Bounes F, Georges B, Guerrero F, Hernandez N, Marcheix B, Seguin T, Minville V, Conil JM, Silva S.

J Intensive Care Med. 2018 Jan 1:885066618776937. doi: 10.1177/0885066618776937. [Epub ahead of print]

PMID:
29768983
9.

Elucidating Solvation Structures for Rational Design of Multivalent Electrolytes-A Review.

Rajput NN, Seguin TJ, Wood BM, Qu X, Persson KA.

Top Curr Chem (Cham). 2018 Apr 26;376(3):19. doi: 10.1007/s41061-018-0195-2. Review.

10.

3-month prognostic impact of severe acute renal failure under veno-venous ECMO support: Importance of time of onset.

Delmas C, Zapetskaia T, Conil JM, Georges B, Vardon-Bounes F, Seguin T, Crognier L, Fourcade O, Brouchet L, Minville V, Silva S.

J Crit Care. 2018 Apr;44:63-71. doi: 10.1016/j.jcrc.2017.10.022. Epub 2017 Oct 18.

PMID:
29073534
11.

Neural signature of coma revealed by posteromedial cortex connection density analysis.

Malagurski B, Péran P, Sarton B, Riu B, Gonzalez L, Vardon-Bounes F, Seguin T, Geeraerts T, Fourcade O, de Pasquale F, Silva S.

Neuroimage Clin. 2017 May 6;15:315-324. doi: 10.1016/j.nicl.2017.03.017. eCollection 2017.

12.

Stacking and Electrostatic Interactions Drive the Stereoselectivity of Silylium-Ion Asymmetric Counteranion-Directed Catalysis.

Seguin TJ, Wheeler SE.

Angew Chem Int Ed Engl. 2016 Dec 19;55(51):15889-15893. doi: 10.1002/anie.201609095. Epub 2016 Nov 17.

PMID:
27860103
13.

Noncovalent Interactions in Organocatalysis and the Prospect of Computational Catalyst Design.

Wheeler SE, Seguin TJ, Guan Y, Doney AC.

Acc Chem Res. 2016 May 17;49(5):1061-9. doi: 10.1021/acs.accounts.6b00096. Epub 2016 Apr 25.

14.

Disruption of posteromedial large-scale neural communication predicts recovery from coma.

Silva S, de Pasquale F, Vuillaume C, Riu B, Loubinoux I, Geeraerts T, Seguin T, Bounes V, Fourcade O, Demonet JF, Péran P.

Neurology. 2015 Dec 8;85(23):2036-44. doi: 10.1212/WNL.0000000000002196. Epub 2015 Nov 11.

15.

Biomimetic Total Syntheses of (-)-Leucoridines A and C through the Dimerization of (-)-Dihydrovalparicine.

Kokkonda P, Brown KR, Seguin TJ, Wheeler SE, Vaddypally S, Zdilla MJ, Andrade RB.

Angew Chem Int Ed Engl. 2015 Oct 19;54(43):12632-5. doi: 10.1002/anie.201505198. Epub 2015 Aug 28.

16.

Enantioselectivity in Catalytic Asymmetric Fischer Indolizations Hinges on the Competition of π-Stacking and CH/π Interactions.

Seguin TJ, Lu T, Wheeler SE.

Org Lett. 2015 Jun 19;17(12):3066-9. doi: 10.1021/acs.orglett.5b01349. Epub 2015 Jun 5.

PMID:
26046695
17.

[Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery].

Bachellerie B, Ruiz S, Conil JM, Crognier L, Seguin T, Georges B, Fourcade O.

Ann Fr Anesth Reanim. 2014 Jan;33(1):44-6. doi: 10.1016/j.annfar.2013.11.011. Epub 2013 Dec 28. French.

PMID:
24378048
18.

Ceftazidime dosage recommendations in burn patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations.

Conil JM, Georges B, Ravat F, Ruiz S, Seguin T, Metsu D, Fourcade O, Saivin S.

Clin Ther. 2013 Oct;35(10):1603-12. doi: 10.1016/j.clinthera.2013.08.014. Epub 2013 Oct 1.

PMID:
24094465
19.

Ceftazidime dosage regimen in intensive care unit patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations.

Georges B, Conil JM, Ruiz S, Seguin T, Cougot P, Fourcade O, Houin G, Saivin S.

Br J Clin Pharmacol. 2012 Apr;73(4):588-96. doi: 10.1111/j.1365-2125.2011.04117.x.

20.

Increased creatinine clearance in polytrauma patients with normal serum creatinine: a retrospective observational study.

Minville V, Asehnoune K, Ruiz S, Breden A, Georges B, Seguin T, Tack I, Jaafar A, Saivin S, Fourcade O, Samii K, Conil JM.

Crit Care. 2011;15(1):R49. doi: 10.1186/cc10013. Epub 2011 Feb 3.

21.

Tobramycin disposition in ICU patients receiving a once daily regimen: population approach and dosage simulations.

Conil JM, Georges B, Ruiz S, Rival T, Seguin T, Cougot P, Fourcade O, Pharmd GH, Saivin S.

Br J Clin Pharmacol. 2011 Jan;71(1):61-71. doi: 10.1111/j.1365-2125.2010.03793.x.

22.

Population pharmacokinetics of ceftazidime in intensive care unit patients: influence of glomerular filtration rate, mechanical ventilation, and reason for admission.

Georges B, Conil JM, Seguin T, Ruiz S, Minville V, Cougot P, Decun JF, Gonzalez H, Houin G, Fourcade O, Saivin S.

Antimicrob Agents Chemother. 2009 Oct;53(10):4483-9. doi: 10.1128/AAC.00430-09. Epub 2009 Jul 27.

23.

Ciprofloxacin use in critically ill patients: pharmacokinetic and pharmacodynamic approaches.

Conil JM, Georges B, de Lussy A, Khachman D, Seguin T, Ruiz S, Cougot P, Fourcade O, Houin G, Saivin S.

Int J Antimicrob Agents. 2008 Dec;32(6):505-10. doi: 10.1016/j.ijantimicag.2008.05.019. Epub 2008 Sep 2.

PMID:
18768301
24.

Cefepime in intensive care unit patients: validation of a population pharmacokinetic approach and influence of covariables.

Georges B, Conil JM, Seguin T, Dieye E, Cougot P, Decun JF, Lavit M, Samii K, Houin G, Saivin S.

Int J Clin Pharmacol Ther. 2008 Apr;46(4):157-64.

PMID:
18397688
25.

Hemodynamic and renal involvement of B1 and B2 kinin receptors during the acute phase of endotoxin shock in mice.

Seguin T, Buleon M, Destrube M, Ranera MT, Couture R, Girolami JP, Tack I.

Int Immunopharmacol. 2008 Feb;8(2):217-21. doi: 10.1016/j.intimp.2007.08.008. Epub 2007 Aug 31.

PMID:
18182230
26.

Pharmacokinetics of ceftazidime and cefepime in burn patients: the importance of age and creatinine clearance.

Conil JM, Georges B, Lavit M, Seguin T, Tack I, Samii K, Chabanon G, Houin G, Saivin S.

Int J Clin Pharmacol Ther. 2007 Oct;45(10):529-38.

PMID:
17966838
27.

[Endothelial progenitor cells: new biomarkers and potential therapy in intensive care].

Seguin T, Braun T, Mira JP.

Med Mal Infect. 2007 Jun;37(6):305-11. Epub 2007 May 23. Review. French.

PMID:
17512151
28.

Intermittent administration of ceftazidime to burns patients: influence of glomerular filtration.

Conil JM, Georges B, Fourcade O, Seguin T, Houin G, Saivin S.

Int J Clin Pharmacol Ther. 2007 Mar;45(3):133-42.

PMID:
17416108
29.

Assessment of renal function in clinical practice at the bedside of burn patients.

Conil JM, Georges B, Fourcade O, Seguin T, Lavit M, Samii K, Houin G, Tack I, Saivin S.

Br J Clin Pharmacol. 2007 May;63(5):583-94. Epub 2006 Dec 7.

30.

[Multiresistant Escherichia coli meningitis after transrectal prostate biopsy].

Samson D, Seguin T, Conil JM, Georges B, Samii K.

Ann Fr Anesth Reanim. 2007 Jan;26(1):88-90. Epub 2006 Dec 8. French.

PMID:
17158017
31.

Increased amikacin dosage requirements in burn patients receiving a once-daily regimen.

Conil JM, Georges B, Breden A, Segonds C, Lavit M, Seguin T, Coley N, Samii K, Chabanon G, Houin G, Saivin S.

Int J Antimicrob Agents. 2006 Sep;28(3):226-30. Epub 2006 Aug 14.

PMID:
16908121
32.

Risk of emergence of Pseudomonas aeruginosa resistance to beta-lactam antibiotics in intensive care units.

Georges B, Conil JM, Dubouix A, Archambaud M, Bonnet E, Saivin S, Lauwers-Cancès V, Cristini C, Cougot P, Decun JF, Mathe O, Chabanon G, Marty N, Seguin T, Houin G.

Crit Care Med. 2006 Jun;34(6):1636-41.

PMID:
16557152
33.

Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen.

Georges B, Conil JM, Cougot P, Decun JF, Archambaud M, Seguin T, Chabanon G, Virenque C, Houin G, Saivin S.

Int J Clin Pharmacol Ther. 2005 Aug;43(8):360-9.

PMID:
16119511

Supplemental Content

Loading ...
Support Center